Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.33 |
| ▸ | PRKCG | P05129 | 2/20 | 0.33 |
| ▸ | PRKCB | P05771 | 2/20 | 0.33 |
| ▸ | PRKCA | P17252 | 2/20 | 0.33 |
| ▸ | PRKCH | P24723 | 2/20 | 0.33 |
| ▸ | PRKCI | P41743 | 2/20 | 0.33 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.33 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.33 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.33 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.33 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28751884 | 0.87 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL6530263 | 0.82 | ALDH1A1 (0.57) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL8322430 | 0.82 | ALDH1A1 (0.34) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL28055861 | 0.81 | ALDH1A1 (0.60) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL27813046 | 0.81 | ALDH1A1 (0.60) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL28241406 | 0.81 | ALDH1A1 (0.60) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL2215380 | 0.80 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL27278259 | 0.79 | — | — | |
| SCHEMBL12045201 | 0.76 | — | — | |
| SCHEMBL51837 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150270574-A1 | HALOGENOSILANE FUNCTIONALIZED CARBONATE ELECTROLYTE MATERIAL, PREPARATION METHOD THEREOF AND USE IN ELECTROLYTE FOR LITHIUM ION BATTERY | GUANGZHOU INSTITUTE OF ENERGY CONVERSION, CHINESE ACADEMY OF SCIENCES (CN) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150270574-A1 | HALOGENOSILANE FUNCTIONALIZED CARBONATE ELECTROLYTE MATERIAL, PREPARATION METHOD THEREOF AND USE IN ELECTROLYTE FOR LITHIUM ION BATTERY | CA1, PIEZO1, SLC9A1 | ALDH1A1 1602/4885PRKD3 1461/4885PRKCG 1895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.